# Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial

> **NCT06778408** · PHASE2 · RECRUITING · sponsor: **University of Vermont Medical Center** · enrollment: 103 (estimated)

## Conditions studied

- Palliative Radiotherapy
- Metastatic Cancer (Different Solid Tumour Types)

## Interventions

- **RADIATION:** Hybrid Palliative Radiation Therapy

## Key facts

- **NCT ID:** NCT06778408
- **Lead sponsor:** University of Vermont Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-28
- **Primary completion:** 2028-02
- **Final completion:** 2028-03
- **Target enrollment:** 103 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06778408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06778408, "Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06778408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*